eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

McNeil Products Ltd

Foundation Park, Roxborough Way, Maidenhead, Berks, SL6 3UG
Medical Information Direct Line: 01344 864042
Medical Information e-mail: medinfo@its.jnj.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?


Summary of Product Characteristics last updated on the eMC: 21/12/2009
SPC Benadryl Skin Allergy Relief Cream


Go to top of the page
1. NAME OF THE MEDICINAL PRODUCT

Benadryl Skin Allergy Relief Cream

Benadryl Allergy Skin Cream


Go to top of the page
2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Benadryl Allergy Skin Cream contains:

1% w/v diphenhydramine hydrochloride Ph Eur

8% w/v zinc oxide Ph Eur

0.1% w/v racemic camphor Ph Eur.


Go to top of the page
3. PHARMACEUTICAL FORM

Cream.


Go to top of the page
4. CLINICAL PARTICULARS

Go to top of the page
4.1 Therapeutic indications

Benadryl Allergy Skin Cream is indicated for the relief of irritation associated with urticaria, herpes zoster and other minor skin affections and alleviate the discomforts of sunburn, prickly heat, insect bites and nettle stings. In infants it may be used for hives.


Go to top of the page
4.2 Posology and method of administration

Adults:

Topical. Benadryl Allergy Skin Cream may be applied to the affected area, three or four times daily.

Children and Infants:

Topical. As for adults.

The Elderly:

Topical. As for adults.


Go to top of the page
4.3 Contraindications

Do not use on chicken pox or measles or exudative dermatoses, unless supervised by a doctor. Do not use on extensive areas of the skin except as directed by a doctor. Do not use any other drugs containing diphenhydramine while using this product.


Go to top of the page
4.4 Special warnings and precautions for use

Benadryl Allergy Skin Cream should not be applied to raw, or broken surfaces or mucous membranes as this may result in percutaneous absorption giving rise to systemic effects. Avoid contact with the eyes. If a burning sensation or rash develops or if the condition persists, treatment should be discontinued. If necessary, remove by washing with soap and water.


Go to top of the page
4.5 Interaction with other medicinal products and other forms of interaction

None known.


Go to top of the page
4.6 Pregnancy and lactation

The safety of Benadryl Allergy Skin Cream in pregnancy and lactation has not been established. Like any medicine, Benadryl Allergy Skin Cream should only be used if the possible benefits outweigh the potential risks involved. Diphenhydramine is known to be absorbed through the skin. Diphenhydramine crosses the placental barrier and is secreted in breast milk.


Go to top of the page
4.7 Effects on ability to drive and use machines

None known.


Go to top of the page
4.8 Undesirable effects

Rarely, sensitivity, eczematous reactions and photosensitivity have been reported after topical application of antihistamines. If this occurs, treatment should be discontinued.


Go to top of the page
4.9 Overdose

Symptoms and signs

Accidental ingestion or excessive absorption of Benadryl Allergy Skin Cream may lead to dose-related signs of diphenhydramine toxicity. These include drowsiness and sedation with anti-cholinergic symptoms prevailing. Camphor may produce nausea, vomiting and dizziness. At higher doses, delirium leading to coma, ataxia, increased muscle reflexes and cloniform convulsions may appear.

Treatment

The stomach should be emptied by lavage and aspiration. In cases of acute poisoning, activated charcoal may be useful. A sodium sulphate purgative may be given. Convulsions may be controlled with diazepam or thiopental sodium. In the case of camphor poisoning, lipid haemodialysis or resin haemoperfusion may be useful.


Go to top of the page
5. PHARMACOLOGICAL PROPERTIES

Go to top of the page
5.1 Pharmacodynamic properties

Benadryl Allergy Skin Cream contains diphenhydramine hydrochloride, zinc oxide and camphor. Diphenhydramine is a powerful antihistamine and local anaesthetic (antipruritic). In concentrations of between 0.1 – 3.0 %, camphor depresses cutaneous receptors and is an effective analgesic, anaesthetic and antipruritic, which provides a feeling of coolness when applied topically.


Go to top of the page
5.2 Pharmacokinetic properties

Benadryl Allergy Skin Cream is intended only for topical application to the skin. At the recommended dose little of the active ingredients will be absorbed. Percutaneous penetration of diphenhydramine and camphor has been demonstrated during inappropriate use of these compounds separately, but has not been quantified.


Go to top of the page
5.3 Preclinical safety data

There are no preclinical data of relevance to the prescriber which are additional to that already included in other sections of the SPC.


Go to top of the page
6. PHARMACEUTICAL PARTICULARS

Go to top of the page
6.1 List of excipients

White ceresin

Cetostearyl alcohol

Ferric oxide red (E172)

Ferric oxide yellow (E172)

Sorbitan stearate

Propyl hydroxybenzoate

Propylene glycol

Polysorbate 60

Perfume oil soleil 78087

Purified water


Go to top of the page
6.2 Incompatibilities

None known.


Go to top of the page
6.3 Shelf life

3 years.


Go to top of the page
6.4 Special precautions for storage

Do not store above 25°C.


Go to top of the page
6.5 Nature and contents of container

Benadryl Allergy Skin Cream is stored in a 42 g epoxy phenolic-based lacquered aluminium tube with a white, polyethylene or polypropylene cap.


Go to top of the page
6.6 Special precautions for disposal and other handling

None applicable.


Go to top of the page
Administrative Data

Go to top of the page
7. MARKETING AUTHORISATION HOLDER

McNeil Products Limited

Foundation Park

Roxborough Way

Maidenhead

Berkshire SL6 3UG

United Kingdom


Go to top of the page
8. MARKETING AUTHORISATION NUMBER(S)

PL 15513/0078


Go to top of the page
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

5th January 2000


Go to top of the page
10. DATE OF REVISION OF THE TEXT

2 December 2009



More information about this product

Link to this document from your website: http://www.medicines.org.uk/emc/medicine/7060/SPC/


Active Ingredients/Generics

 
   zinc oxide
   diphenhydramine hydrochloride
   camphor